BioArctic AB

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About BioArctic AB
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
Frequently asked questions
To buy BioArctic AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioArctic AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioArctic AB is BIOA_B:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioArctic AB has its primary listing on NASDAQ OMX Stockholm. You can trade BioArctic AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioArctic AB is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include BioArctic AB as part of a broader investment portfolio.